US Stock MarketDetailed Quotes

HLVX HilleVax

Watchlist
  • 1.920
  • +0.010+0.52%
Close Nov 27 16:00 ET
  • 1.920
  • 0.0000.00%
Post 16:02 ET
95.63MMarket Cap-621P/E (TTM)

About HilleVax Company

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

Company Profile

SymbolHLVX
Company NameHilleVax
Listing DateApr 29, 2022
Issue Price17.00
Founded2020
CEODr. Robert M. Hershberg, M.D.,PhD
MarketNASDAQ
Employees90
Fiscal Year Ends12-31
Address321 Harrison Avenue,Suite 500
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-617-213-5054
Websitehttp://www.hillevax.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 9.70M
  • Aditya Kohli, PhD
  • Director and Chief Business Officer
  • 4.08M
  • Paul S. Bavier
  • General Counsel and Chief Administrative Officer
  • --
  • Shane Maltbie
  • Vice of President, Finance, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Astrid Borkowski, M.D.,PhD
  • Chief Medical Officer
  • 2.84M
  • Sean McLoughlin
  • Chief Operating Officer
  • --
  • Dr. Gary Dubin, M.D.
  • Director
  • --
  • Jeryl L. Hilleman
  • Independent Director
  • 375.11K
  • Patrick J. Heron
  • Independent Director
  • 367.11K
  • Dr. Nanette Cocero, M.B.A.,PhD
  • Independent Director
  • 555.03K
  • Dr. Julie L. Gerberding, M.D.,M.P.H.
  • Independent Director
  • 365.93K
  • Dr. Jaime Sepulveda, D.Sc.,M.D.,M.P.H.
  • Independent Director
  • 353.11K
  • Dr. Shelley Chu, PhD
  • Independent Director
  • 355.11K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data